BriaCell Therapeutics Corp - Ordinary Shares - New

XNAS:BCTX  
11.39
-0.85 (-6.94%)
7:03:18 PM EDT: $11.83 +0.44 (+3.85%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)19.97M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.1 Million
Adjusted EPS-$3.28
See more estimates
10-Day MA$10.62
50-Day MA$11.13
200-Day MA$22.73
See more pivots

BriaCell Therapeutics Corp - Ordinary Shares - New Stock, XNAS:BCTX

Bellevue Centre, 235 -15th Street, West Vancouver, British Columbia V7T 2X1
Canada
Phone: +1.604.921.1810
Number of Employees: 18
http://www.briacell.com

Description

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMTâ„¢ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.